TrialX-Powered App Studying Antibiotic Resistance Completes Enrollment, Seizure Forecasting App Goes Live, DPharm 2025 Highlights & More…
TrialX, in collaboration with investigators at the University of Iowa is proud to announce that the SAYSTOP Study App, developed to study antibiotic resistance using our remote data collection solution, has successfully completed enrollment. The “Study of Antibiotics You Stop for Treatment Of Pyelonephritis (SAYSTOP),” is exploring whether it is safe for patients with urinary tract infections to stop antibiotics when they feel better compared to completing the full course. The app enables participants to track and manage their antibiotic use. We are glad and honored that the investigators and study team felt supported throughout the process, sharing: “Given the limited budget, TrialX team was incredibly patient, responsive, and committed to helping us achieve our goals. They consistently worked with us to accommodate our requests and adjustments, and we appreciate their flexibility and dedication throughout the process.” We are proud to support groundbreaking research like SAYSTOP in addressing the urgent global challenge of antibiotic resistance.
What’s New at TrialX! 🚀
❇️ DPHARM 2025 HIGHLIGHTS
🚀At the recently held DPHARM 2025 conference, our team joined the conversation on how AI is transforming patient engagement. From keynote insights to real-world applications, the event highlighted the future of AI in clinical trials and patient-first innovation. We shared how TrialX is leveraging AI to advance patient recruitment and remote data collection—and explored opportunities to drive innovation together. Here are the highlights.
📢 PRODUCT UPDATES
We are proud to support Montefiore Medical Center and the University of Cincinnati in launching the FORETELL-Epilepsy app, an NIH-funded initiative to advance seizure forecasting and improve patient care. The app enables adults living with epilepsy to contribute real-world data through daily diaries of seizures, mood, and stress, while integrating with wearable devices to track heart rate and sleep. The app is live and available on both app stores, with enrollment currently in progress. Learn more.
Space missions demand health monitoring in environments with limited connectivity and extreme conditions—where traditional tools often fall short. TrialX Space Health Systems is an offline-capable, AI-powered platform that collects and analyzes diverse datasets, from wearables to genomics, even beyond Earth’s grid. Remote health research is possible, wherever the mission goes. Learn More.
🎤️ UNSUNG BUT IMPACTFUL VOICES OF CLINICAL RESEARCH HEROES
Sometimes the most meaningful change happens behind the scenes—through patient conversations, steady guidance, and quiet determination. In our blog series Unsung But Impactful Voices of Clinical Research Heroes, we’re honoring the professionals who bring clinical research to life in deeply personal ways. This month, we’re proud to feature Aby Dia, Clinical Research Navigator at the HCLTech Clinical Research Contact Center. With roots in behavioral therapy and a strong belief in advocacy, Aby helps patients and caregivers understand their choices and move forward with confidence. Read her full story.
RECENT CURETALKS 
🧬 FEATURED CLINICAL STUDIES
Powered by TrialX
The AHORA! Study: Indiana University researchers are exploring ways to improve participation of Hispanic and White non-Hispanic adults in Alzheimer’s disease research. Participants aged 55+ complete a one-time 25-minute survey via phone or online to share their beliefs about Alzheimer’s, as well as barriers and motivators for joining research studies
The TUNE IN Study: Researchers at Penn Medicine are testing TUNE In, a social skills program for autistic adults. Rooted in cognitive-behavioral therapy and mindfulness, TUNE In helps participants improve social understanding, notice cues, and interact authentically without masking autistic traits.
The ALLEGRO 100 Study: Pfizer researchers are testing ritlecitinib, an FDA-approved pill, to see if a 100 mg daily dose is safe and effective for regrowing hair in people with severe alopecia areata. Participants aged 12+ who have lost at least 50% of scalp hair and are in a current hair-loss episode will take the pill daily for up to 48 weeks, with about 9 study visits and a follow-up 4 weeks after the last dose.
The Food Literacy Study: Researchers in Pennsylvania are testing whether a preschool nutrition program can help young children (ages 3–5) learn about healthy foods and make better food choices. The study runs for about 14 months and aims to reduce childhood obesity risk by improving food knowledge and acceptance.
🌎 AROUND THE WEB
🤖 Smarter trials: Agentic AI will soon be running clinical trial workflows on its own.
🚀 Life on Mars: Elon Musk says we could settle on the Red Planet by 2055.
💊 Ozempic in a pill? Oral semaglutide could make weight loss way easier.
🎯 Breast cancer breakthrough: This new strategy shows progress against one of the toughest diseases.
🧬 Space-aging alert: Stem cells age faster in space—what it means for astronauts.
‼️ NOTEWORTHY
TEAM UPDATES
🎊 Welcoming New Members
We are glad to have Elizabeth Dickson on our team as VP, Business Development. Beth has over 17 years of experience in clinical research operations, including patient recruitment, site feasibility, contract negotiation, proposal development, and strategic sales. Known for driving operational efficiency and delivering measurable value to clients, she brings a collaborative leadership style, deep industry insight, and a proven ability to build and scale successful partnerships across the clinical trial ecosystem.
We are also excited to have Abigail Watson on our team as Advanced Informatics Consultant. Abbie brings 20 years of experience and a diverse background spanning large urban hospitals, federally funded laboratories, and startups. She has applied her expertise across healthcare and aerospace engineering environments, including roles with the FAA Office of Aerospace Medicine, the Center for Advanced Aviation System Development, and the CMS Alliance for Modernizing Healthcare.
At TrialX, we strive to revolutionize the way clinical trials are conducted on earth and in space, by focusing on innovative solutions to streamline patient recruitment and remote data collection. Stay tuned for more updates as we continue to look up to the Moon & Mars!
